drugset / Trial / NCT05517668

Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose

NCT05517668

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is a randomized, placebo-controlled double-blinded clinical trial of patients presenting with acetaminophen poisoning who are at increased risk of developing liver injury. With this trial the investigators are hoping to show the superiority of acetylcysteine (NAC) + fomepizole (4-MP) compared to treatment with acetylcysteine alone. The primary objective of this trial is to determine the effect of fomepizole on the severity of acute liver injury in patients with acetaminophen poisoning.

Timeline

Start
2022-09-12
Primary completion
2025-10-31
Completion
2025-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fomepizole Small molecule 10 mg/kg Intravenous
Background N-acetylcysteine Small molecule 6.25 mg/kg Intravenous